Catalyst
Slingshot members are tracking this event:
Top-line data of Part A Phase 2/3 IV CR845 in treating Uremic pruritus due 1Q 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
CARA | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 28, 2017
Occurred Source:
http://ir.caratherapeutics.com/releasedetail.cfm?ReleaseID=1018995
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Iv Cr845, Uremic Pruritus, Phase 2/3